2011 US-HUPO Conference -- Proteomics: New Developments and Grand Challenges

2011年US-HUPO会议——蛋白质组学：新进展与重大挑战

• 批准号: 8128049
• 负责人: David C. Muddiman
• 金额: $ 2.5万
• 依托单位: NORTH CAROLINA STATE UNIVERSITY RALEIGH
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-03-18 至 2012-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8128049
• 关键词: Address; Affect; Animal Model; Biological; Biological Assay; Biological Markers; Biosensor; Businesses; Cardiovascular Diseases; Cells; Clinic; Clinical; Coffee; Collaborations; Communicable Diseases; Complement; Country; Development; Diabetes Mellitus; Diagnostic; Disabled Persons; Discipline; Disease; Early Diagnosis; Educational Activities; Educational workshop; Experimental Designs; Faculty; Feedback; Fostering; Foundations; Funding; Funding Applicant; Future; Goals; Growth; Health; Historically Black Colleges and Universities; Human; Institution; Intervention; Laboratories; Learning; Liquid substance; Mails; Malignant Neoplasms; Maryland; Mass Spectrum Analysis; Methods; Minority; Minority Groups; Minority-Serving Institution; Mission; North Carolina; Obesity; Oral; Participant; Persons; Postdoctoral Fellow; Protein Microchips; Proteins; Proteome; Proteomics; Published Comment; Records; Recruitment Activity; Research; Research Personnel; Scientist; Site; Societies; Solutions; South Carolina; Students; Technology; Thinking; Time; Training; Translating; Translations; Underrepresented Minority; United States; Universities; Validation; Virginia; Woman; abstracting; base; career; cell growth regulation; clinical application; clinical assay development; density; design; graduate student; handicapping condition; human disease; human tissue; improved; innovation; interest; medical schools; meetings; member; nervous system disorder; new technology; novel; operation; outcome forecast; posters; prognostic; programs; social; symposium; translational medicine; treatment strategy

DESCRIPTION (provided by applicant): We request partial funding support for operation of the 2011 Annual Meeting of the United States Human Proteome Organization (US-HUPO) entitled "Proteomics: New Developments and Grand Challenges", to be held March 20-23, 2011 in Raleigh, North Carolina. This meeting has been and continues to be a vital conference for the highly interdisciplinary scientific field of proteomics directed towards biological and clinical questions. US-HUPO is a unique meeting of scientists because it truly reflects the multiple disciplines, strategies, and technologies for which proteomics encompasses to enable this field to approach and solve sophisticated biomedical problems and provide perspective and accomplishments on how these findings can be translated into the clinic for diagnostic, prognostic and treatment purposes. The field is rich with diverse technological platforms including mass spectrometry, protein microarrays, biosensors, clinical assays, and biomarker discovery and validation. The first meeting of US-HUPO was in 2005 and what has evolved is a program that has provided the scientific foundation that has propelled the field of proteomics forward in rapid fashion. The conference is heavily attended and has always attracted first-rate speakers in this field. The 2011 Annual Meeting will again bring together an outstanding and diverse group of scientists at the forefront of proteomics. Invited speakers in the symposium will explicitly discuss applications relevant to a wide range of diseases including cardiovascular disease, cancer, and infectious diseases. The technological advances that have been made in the recent year are of critical importance to allow scientists to more effectively address biological problems and thus, this will also be a hallmark of the meeting. The topics chosen will educate participants on the latest, most effective technologies and methods, illustrate successful translation of these technologies into the clinic, and highlight new directions and grand challenges for the future of this field. Panel discussions will be held on key topics in order to encourage a robust dialogue between speakers and meeting participants to discuss critical goals for the future in proteomics, outline anticipated obstacles, and brainstorm solutions. This year US- HUPO will introduce a Business Meeting in the program to allow the participants to understand the mission and details of US-HUPO and thus allow for direct feedback from those in attendance to further improve the meeting. The poster sessions will also offer a more informal exchange of scientific ideas and advances. Ample time will be devoted to social venues for attendees to meet each other and establish new contacts and collaborations. Currently, 33% of the invited speakers are either women or members of minority groups and 33% are new investigators (Assistant/Associate Level). Attendance is expected to be 350-450 participants, including 100-150 students/post A docs. Registration is not restricted, and all interested persons may attend. A special effort will be made to recruit minority and industrial participants; the latter should be readily achievable given that Research Triangle Park is only 15 minutes from downtown Raleigh. Participants will present posters on new findings each afternoon. Importantly, the conference provides a forum for young investigators to see the connection between fundamental scientific inquiry and the application of scientific methods to the design of efficacious interventions for human disease. To emphasize this goal, over 20 poster presentations that complement the themes of the meeting will be selected for short oral presentations during the concurrent sessions. Finally, it is important to note that preceding the meeting, US-HUPO offer several Full-Day and Half-Day short courses on contemporary topics in proteomics. PUBLIC HEALTH RELEVANCE (provided by applicant): Funding is requested to support the 2011 Annual Meeting of the United States Human Proteome Organization (US-HUPO), whose mission is to promote scientific and educational activities to encourage the use of new technologies for analyzing proteins in human tissues and fluids, and model organisms, with the ultimate goal of developing critically needed methods for early diagnosis, prognosis of human diseases and new therapies for treating contemporary health problems that affect millions of people worldwide.

描述（由申请人提供）：我们要求为2011年3月20日至23日在北卡罗来纳州罗利举行的美国人类蛋白质组组织（US-HUPO）的2011年年度会议的部分资金支持。这次会议曾经并且继续是针对生物学和临床问题的高度跨学科科学领域的重要会议。美国 - 赫普（Us-Hupo）是科学家的独特会议，因为它确实反映了蛋白质组学所包含的多个学科，策略和技术，以使该领域能够解决并解决复杂的生物医学问题，并为如何将这些发现转化为诊断，预后和治疗目的。该领域具有多种技术平台，包括质谱，蛋白质微阵列，生物传感器，临床测定法以及生物标志物发现和验证。 US-HUPO的第一次会议是在2005年，而进化的计划则提供了科学基础，该基金会以快速的方式推动了蛋白质组学领域。会议大量参加，并且一直吸引着该领域的一流演讲者。 2011年的年度会议将再次将一群杰出而多样的科学家汇集在蛋白质组学的最前沿。研讨会上的受邀演讲者将明确讨论与多种疾病有关的应用，包括心血管疾病，癌症和传染病。最近一年取得的技术进步对于允许科学家更有效地解决生物学问题至关重要，因此，这也将是会议的标志。所选的主题将教育参与者有关最新，最有效的技术和方法的教育，这说明了这些技术的成功翻译为诊所，并突出了该领域未来的新方向和巨大的挑战。小组讨论将在关键主题上举行，以鼓励演讲者和会议参与者之间进行强有力的对话，以讨论蛋白质组学，概述预期的障碍和头脑风暴解决方案的关键目标。今年美国将在该计划中介绍一次商务会议，以允许参与者了解US-HUPO的使命和详细信息，从而允许出席人员的直接反馈，以进一步改善会议。海报会议还将提供更非正式的科学思想和进步交流。充足的时间将用于社交场所，供与会者见面并建立新的联系和合作。目前，有33％的受邀演讲者是妇女或少数群体的成员，33％是新的调查人员（助理/助理一级）。预计出勤率为350-450名参与者，包括100-150名学生/邮寄文档。注册不受限制，所有感兴趣的人都可以参加。将为招募少数民族和工业参与者做出特别的努力；鉴于研究三角公园距离罗利市中心仅15分钟路程，因此应该很容易实现。参与者每天下午都会在新发现上介绍海报。重要的是，该会议为年轻的研究人员提供了一个论坛，以查看基本科学探究与科学方法在设计人类疾病有效干预措施上的应用之间的联系。为了强调这一目标，将在同时会议期间选择与会议主题相辅相成的20多个海报演示。最后，重要的是要注意，在会议之前，Us-Hupo为蛋白质组学中的当代主题提供了几门全天和半天的简短课程。 公共卫生相关性（由申请人提供）：要求资金支持2011年美国人类蛋白质组组织（US-HUPO）的2011年度会议，其使命是促进科学和教育活动，以鼓励使用新技术来分析人类组织和流体中的蛋白质，并在早期诊断中疾病，并为新的诊断症状而建模，并在早期诊断中进行验证，并涉及新技术的最终疾病，并且是对早期诊断的最终目标，即对人类的最终疾病的疾病，并涉及人类的最终疾病，并有助于培养人类的疾病，并有助于培养人类的疾病。影响全球数百万人的问题。